EU seeks to in­cen­tivize an­timi­cro­bial drug de­vel­op­ment as part of pro­posed phar­ma re­forms

The EU is plan­ning on in­tro­duc­ing some of the largest re­forms to phar­ma­ceu­ti­cal de­vel­op­ment in the 27-na­tion bloc lat­er this month. While the en­tire­ty of the de­tails re­mains undis­closed, we now know some more of what that could en­tail.

EU Health Com­mis­sion­er Stel­la Kyr­i­akides said in a speech Mon­day that the re­forms, sched­uled to be pre­sent­ed in the EU lat­er this quar­ter, have two ob­jec­tives: to ad­dress pa­tient in­ter­est across Eu­rope and ful­ly sup­port “an in­no­v­a­tive and glob­al­ly com­pet­i­tive EU in­dus­try.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER